CTDNA
Clinical trials for CTDNA explained in plain language.
Never miss a new study
Get alerted when new CTDNA trials appear
Sign up with your email to follow new studies for CTDNA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets 'Hidden' colon cancer after chemo
Disease control Recruiting nowThis study is testing whether a combination of two drugs, fruquintinib and tislelizumab, can help control colorectal cancer in patients who have finished their initial chemotherapy but still have tiny amounts of cancer left in their body, detected by a special blood test. The goa…
Matched conditions: CTDNA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 19:41 UTC
-
Blood test guides new cancer treatment strategy
Disease control Recruiting nowThis study is testing a combination treatment for advanced esophageal cancer that cannot be removed by surgery. Patients receive immunotherapy and chemotherapy first, followed by radiation with chemotherapy. Researchers will use regular blood tests to track tiny cancer DNA fragme…
Matched conditions: CTDNA
Phase: NA • Sponsor: The Central Hospital of Lishui City • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Blood test could personalize cancer care, help doctors decide when to change treatment
Disease control Recruiting nowThis study is testing if a simple blood test can help doctors make better treatment decisions for people with advanced breast cancer that has spread. Researchers will track tiny pieces of cancer DNA in the blood to see if changes can predict how well a treatment is working early …
Matched conditions: CTDNA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New blood test aims to spot deadly bile duct cancer earlier
Diagnosis Recruiting nowThis study is testing a new blood test designed to improve the detection and management of bile duct cancers, which are often diagnosed late and have poor survival rates. The test looks for specific chemical markers released by cancer cells into the bloodstream. Researchers will …
Matched conditions: CTDNA
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC